Results 41 to 50 of about 28,545 (222)

Correlation from undiluted vitreous cytokines of untreated central retinal vein occlusion with spectral domain optical coherence tomography [PDF]

open access: yes, 2013
Purpose: To correlate inflammatory and proangiogenic key cytokines from undiluted vitreous of treatment-naïve central retinal vein occlusion (CRVO) patients with SD-OCT parameters. Methods: Thirty-five patients (age 71.1 years, 24 phakic, 30 nonischemic)
Cinatl, Jindrich   +8 more
core   +1 more source

Fingolimod: therapeutic mechanisms and ocular adverse effects. [PDF]

open access: yes, 2017
Fingolimod is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). We aim to review the published literature on ocular manifestations of fingolimod therapy and their possible underlying mechanisms.
A Groves   +40 more
core   +1 more source

Long-term management of non-ischemic central retinal vein occlusion with fluocinolone acetonide intravitreal implant 190 μg (ILUVIEN®)

open access: yesTherapeutic Advances in Ophthalmology, 2019
Introduction: Macular edema after central retinal vein occlusion is a common cause of vision loss. Upregulation of vascular endothelial growth factor and higher levels of inflammatory mediators have been involved in the pathogeny of the macular edema in ...
João Coelho   +2 more
doaj   +1 more source

ROLE OF BEVACIZUMAB FOR PREVENTION OF NEOVASCULAR GLAUCOMA IN ACUTE RETINAL VEIN OCCLUSION [PDF]

open access: yesJournal of University Medical & Dental College, 2018
: There is a possibility of developing neovascular glaucoma in ischemic type of retinal vein occlusion. Purpose of the study is to determine the role of anti VEGF agent bevacizumab for prevention of neovascular glaucoma in ischemic type of retinal vein ...
Bassam Mubarik , Adeen Akram
doaj   +1 more source

Severe visual impairment due to an optic neuropathy and central retinal vein occlusion in a sarcoidosis patient

open access: yesJournal of Ophthalmic Inflammation and Infection, 2020
Background The ophthalmic manifestation of neurosarcoidosis is varied. The complication of optic neuropathy and central retinal vein occlusion (CRVO) is rare in sarcoidosis.
Miki Hiraoka
doaj   +1 more source

Retinal vascular occlusion in patients with the Covid-19 virus

open access: yesInternational Journal of Retina and Vitreous, 2022
Background The coronavirus disease (COVID-19) can cause acute respiratory distress syndrome with dyspnea, anosmia, fever, and cough. Few studies describing ocular findings have been reported.
Helio F. Shiroma   +7 more
doaj   +1 more source

Treating macular edema following RVO [PDF]

open access: yes, 2014
Retinal vein occlusion (RVO) affects 16 million people worldwide, usually the middle-aged or older. It is caused by thrombosis, the clogging of the retinal veins, which may occur in the four branch veins – branch vein retinal occlusion (BVRO), or in the ...
Hrytsay, T.
core  

Oral Celastrol Nanomedicine Targeting Intestinal Antigen‐Presenting Cells to Effectively Mitigate Autoimmune Uveitis via Gut‐Retina Axis

open access: yesAdvanced Science, EarlyView.
Oral nanoCEL exhibits effective intestinal targeting of antigen‐presenting cells and restores the Th17/Treg balance in lymph nodes and spleen, ultimately protecting the blood‐retinal barrier by inhibiting peripheral immune cell infiltration and suppressing retinal glial cell activation.
Jinrun Chen   +13 more
wiley   +1 more source

Acute Central Retinal Vein Occlusion Secondary to Reactive Thrombocytosis after Splenectomy

open access: yesCase Reports in Ophthalmological Medicine, 2014
The diagnosis and treatment of central retinal vein occlusion was reported in a young patient. Central retinal vein occlusion was probably related to secondary to reactive thrombocytosis after splenectomy.
Nursen Oncel Acir   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy